Research view
Switch to patient viewColorectal cancer: trials that stopped early
Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.
Terminated
Radioembolization in Elderly/ Fragile Patients With mCRC
Reason given in the registry “The medical deviced studied was taken off market”
Quoted unchanged from ClinicalTrials.gov; record updated 14 May 2026.
- Ended
- Sept 2025
- Phase
- Phase 2
- Run by
- UMC Utrecht
- Registry record
- NCT05092880
Terminated
Testing Obeticholic Acid for Familial Adenomatous Polyposis
Reason given in the registry “Protocol has been completed prematurely due to poor accrual and study feasibility.”
Quoted unchanged from ClinicalTrials.gov; record updated 14 May 2026.
- Ended
- Apr 2026
- Phase
- Phase 2
- Run by
- National Cancer Institute (NCI)
- Registry record
- NCT05223036
Suspended
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Reason given in the registry “Due to slow accrual on this trial, we will allow sites time to work on close-out procedures and filling out necessary paperwork before taking the steps to forma”
Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2026.
- Run by
- National Cancer Institute (NCI)
- Registry record
- NCT04955808
Terminated
A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients
Reason given in the registry “After interim-analysis: No signals of clinical or immunological efficacy detected, and decision was made not to continue the trial.”
Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2026.
- Ended
- May 2025
- Phase
- Phase 1/2
- Run by
- Oslo University Hospital
- Registry record
- NCT04550897
Terminated
Defunctioning Left-sided Colostomy in Low Anterior Resection for Rectal Cancer
Reason given in the registry “Logistical difficulties at study sites. 16/20 patients included.”
Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2026.
- Ended
- Jul 2025
- Run by
- Umeå University
- Registry record
- NCT06149741
Suspended
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
Reason given in the registry “enrollment goal met pending determination of evaluable subjects”
Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2026.
- Phase
- Phase 1/2
- Run by
- University of Chicago
- Registry record
- NCT05200442
Suspended
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Reason given in the registry “Because the implementation of the new regulation policy by the Chinese authority”
Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.
- Phase
- Early phase 1
- Run by
- Wondercel Biotech (ShenZhen)
- Registry record
- NCT06675513
Suspended
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
Reason given in the registry “Because the implementation of the new regulation policy by the Chinese authority”
Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.
- Phase
- Early phase 1
- Run by
- Wondercel Biotech (ShenZhen)
- Registry record
- NCT06653010
Terminated
Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.
Reason given in the registry “The mid-term analysis of the study showed no significant difference between the two groups.”
Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.
- Ended
- Dec 2024
- Run by
- Sun Peng
- Registry record
- NCT05494658
Terminated
A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors
Reason given in the registry “The trial was terminated for strategic reasons. The decision was not based on any safety concerns”
Quoted unchanged from ClinicalTrials.gov; record updated 5 May 2026.
- Ended
- Apr 2026
- Phase
- Phase 1
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
- Registry record
- NCT05983133
Suspended
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Reason given in the registry “Pending Protocol amendment”
Quoted unchanged from ClinicalTrials.gov; record updated 4 May 2026.
- Run by
- Rutgers, The State University of New Jersey
- Registry record
- NCT04929015
Suspended
Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy
Reason given in the registry “Issues with applicator”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Apr 2026.
- Run by
- Sir Mortimer B. Davis - Jewish General Hospital
- Registry record
- NCT04336202
Terminated
"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"
Reason given in the registry “lack of inclusion”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Apr 2026.
- Ended
- Dec 2025
- Run by
- Nantes University Hospital
- Registry record
- NCT03876561
Terminated
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers
Reason given in the registry “Patient recruitment problems.”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2026.
- Ended
- Feb 2026
- Phase
- Phase 2
- Run by
- Aurigene Discovery Technologies Limited
- Registry record
- NCT06760702
Terminated
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies
Reason given in the registry “Patient recruitment problems”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2026.
- Ended
- Feb 2026
- Phase
- Phase 1
- Run by
- Aurigene Discovery Technologies Limited
- Registry record
- NCT05861947
Terminated
Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study
Reason given in the registry “Study terminated per sponsor decision due to operational reasons. The termination was not a result of any participant safety concerns.”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Apr 2026.
- Ended
- Mar 2026
- Run by
- Harbinger Health
- Registry record
- NCT07479381
Terminated
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Reason given in the registry “The drug supply expired and the sponsor is unable to provide an updated supply.”
Quoted unchanged from ClinicalTrials.gov; record updated 8 Apr 2026.
- Ended
- Apr 2025
- Phase
- Early phase 1
- Run by
- Stephan Rogalla
- Registry record
- NCT06034197
Withdrawn
Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer
Reason given in the registry “The study has been halted because the manufacturer can no longer supply the experimental treatment”
Quoted unchanged from ClinicalTrials.gov; record updated 6 Apr 2026.
- Phase
- Phase 2
- Run by
- Assistance Publique - Hôpitaux de Paris
- Registry record
- NCT06152523
Terminated
Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients
Reason given in the registry “As the laboratory due to carry out the biological analyses withdrew, the project did not go ahead”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Mar 2026.
- Ended
- Mar 2026
- Run by
- Centre Hospitalier Universitaire Dijon
- Registry record
- NCT04523389
Terminated
Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis
Reason given in the registry “safety was ok, but efficacy was considered too low - it was decided not to continue woth this study design”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Mar 2026.
- Ended
- Dec 2025
- Run by
- Contipro Pharma a.s.
- Registry record
- NCT07490080
Terminated
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
Reason given in the registry “The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns”
Quoted unchanged from ClinicalTrials.gov; record updated 23 Mar 2026.
- Ended
- Jul 2025
- Phase
- Phase 1
- Run by
- Pfizer
- Registry record
- NCT06580938
Terminated
Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
Reason given in the registry “Lack of eligible patients”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Mar 2026.
- Ended
- Oct 2024
- Run by
- Centre Oscar Lambret
- Registry record
- NCT06181201
Withdrawn
Structured TXI-RDI Integration for Endoscopic Resection
Reason given in the registry “Not funded”
Quoted unchanged from ClinicalTrials.gov; record updated 16 Mar 2026.
- Run by
- Medical College of Wisconsin
- Registry record
- NCT07474844
Withdrawn
A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer
Reason given in the registry “0 participants enrolled”
Quoted unchanged from ClinicalTrials.gov; record updated 11 Mar 2026.
- Ended
- Jan 2026
- Phase
- Phase 1/2
- Run by
- M.D. Anderson Cancer Center
- Registry record
- NCT07137390
Suspended
Cryotherapy & Oxaliplatin
Reason given in the registry “Study paused to enrollment”
Quoted unchanged from ClinicalTrials.gov; record updated 6 Mar 2026.
- Run by
- NYU Langone Health
- Registry record
- NCT06281925
Withdrawn
Behavioral Nudge in Colorectal Cancer Screening
Reason given in the registry “Study was discontinued due to a lack of feasibility.”
Quoted unchanged from ClinicalTrials.gov; record updated 25 Feb 2026.
- Ended
- Jul 2026
- Run by
- NYU Langone Health
- Registry record
- NCT06796049
Withdrawn
A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
Reason given in the registry “0 participants enrolled”
Quoted unchanged from ClinicalTrials.gov; record updated 25 Feb 2026.
- Ended
- Jan 2026
- Phase
- Phase 2
- Run by
- M.D. Anderson Cancer Center
- Registry record
- NCT07223567
Terminated
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
Reason given in the registry “The study was terminated by sponsor based on the adverse event profile.”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Feb 2026.
- Ended
- Jan 2026
- Phase
- Phase 1
- Run by
- Accent Therapeutics
- Registry record
- NCT06625515
Terminated
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Reason given in the registry “Study terminated as part of strategic considerations and not based on safety concerns.”
Quoted unchanged from ClinicalTrials.gov; record updated 23 Feb 2026.
- Ended
- Oct 2025
- Phase
- Phase 1
- Run by
- Pfizer
- Registry record
- NCT06546553
Terminated
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Reason given in the registry “At the time of the primary analysis, results did not meet the primary endpoint”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Feb 2026.
- Ended
- Mar 2025
- Phase
- Phase 2
- Run by
- Inspirna, Inc.
- Registry record
- NCT05983367
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.